Automated Movement Detection with Dirichlet Process Mixture Models and Electromyography

Numerous sleep disorders are characterised by movement during sleep, these include rapid-eye movement sleep behaviour disorder (RBD) and periodic limb movement disorder. The process of diagnosing movement related sleep disorders requires laborious and time-consuming visual analysis of sleep recordings. This process involves sleep clinicians visually inspecting electromyogram (EMG) signals to identify abnormal movements. The distribution of characteristics that represent movement can be diverse and varied, ranging from brief moments of tensing to violent outbursts. This study proposes a framework for automated limb-movement detection by fusing data from two EMG sensors (from the left and right limb) through a Dirichlet process mixture model. Several features are extracted from 10 second mini-epochs, where each mini-epoch has been classified as 'leg-movement' or 'no leg-movement' based on annotations of movement from sleep clinicians. The distributions of the features from each category can be estimated accurately using Gaussian mixture models with the Dirichlet process as a prior. The available dataset includes 36 participants that have all been diagnosed with RBD. The performance of this framework was evaluated by a 10-fold cross validation scheme (participant independent). The study was compared to a random forest model and outperformed it with a mean accuracy, sensitivity, and specificity of 94\%, 48\%, and 95\%, respectively. These results demonstrate the ability of this framework to automate the detection of limb movement for the potential application of assisting clinical diagnosis and decision-making

Bio-signal based control in assistive robots: a survey

Recently, bio-signal based control has been gradually deployed in biomedical devices and assistive robots for improving the quality of life of disabled and elderly people, among which electromyography (EMG) and electroencephalography (EEG) bio-signals are being used widely. This paper reviews the deployment of these bio-signals in the state of art of control systems. The main aim of this paper is to describe the techniques used for (i) collecting EMG and EEG signals and diving these signals into segments (data acquisition and data segmentation stage), (ii) dividing the important data and removing redundant data from the EMG and EEG segments (feature extraction stage), and (iii) identifying categories from the relevant data obtained in the previous stage (classification stage). Furthermore, this paper presents a summary of applications controlled through these two bio-signals and some research challenges in the creation of these control systems. Finally, a brief conclusion is summarized

Proceedings of the Sixth Deep Brain Stimulation Think Tank Modulation of Brain Networks and Application of Advanced Neuroimaging, Neurophysiology, and Optogenetics

The annual deep brain stimulation (DBS) Think Tank aims to create an opportunity for a multidisciplinary discussion in the field of neuromodulation to examine developments, opportunities and challenges in the field. The proceedings of the Sixth Annual Think Tank recapitulate progress in applications of neurotechnology, neurophysiology, and emerging techniques for the treatment of a range of psychiatric and neurological conditions including Parkinson’s disease, essential tremor, Tourette syndrome, epilepsy, cognitive disorders, and addiction. Each section of this overview provides insight about the understanding of neuromodulation for specific disease and discusses current challenges and future directions. This year’s report addresses key issues in implementing advanced neurophysiological techniques, evolving use of novel modulation techniques to deliver DBS, ans improved neuroimaging techniques. The proceedings also offer insights into the new era of brain network neuromodulation and connectomic DBS to define and target dysfunctional brain networks. The proceedings also focused on innovations in applications and understanding of adaptive DBS (closed-loop systems), the use and applications of optogenetics in the field of neurostimulation and the need to develop databases for DBS indications. Finally, updates on neuroethical, legal, social, and policy issues relevant to DBS research are discussed

Deep Learning for Processing Electromyographic Signals: a Taxonomy-based Survey

Deep Learning (DL) has been recently employed to build smart systems that perform incredibly well in a wide range of tasks, such as image recognition, machine translation, and self-driving cars. In several fields the considerable improvement in the computing hardware and the increasing need for big data analytics has boosted DL work. In recent years physiological signal processing has strongly benefited from deep learning. In general, there is an exponential increase in the number of studies concerning the processing of electromyographic (EMG) signals using DL methods. This phenomenon is mostly explained by the current limitation of myoelectric controlled prostheses as well as the recent release of large EMG recording datasets, e.g. Ninapro. Such a growing trend has inspired us to seek and review recent papers focusing on processing EMG signals using DL methods. Referring to the Scopus database, a systematic literature search of papers published between January 2014 and March 2019 was carried out, and sixty-five papers were chosen for review after a full text analysis. The bibliometric research revealed that the reviewed papers can be grouped in four main categories according to the final application of the EMG signal analysis: Hand Gesture Classification, Speech and Emotion Classification, Sleep Stage Classification and Other Applications. The review process also confirmed the increasing trend in terms of published papers, the number of papers published in 2018 is indeed four times the amount of papers published the year before. As expected, most of the analyzed papers (≈60 %) concern the identification of hand gestures, thus supporting our hypothesis. Finally, it is worth reporting that the convolutional neural network (CNN) is the most used topology among the several involved DL architectures, in fact, the sixty percent approximately of the reviewed articles consider a CNN

Wearables, smartphones, and artificial intelligence for digital phenotyping and health

Ubiquitous progress in wearable sensing and mobile computing technologies, alongside growing diversity in sensor modalities, has created new pathways for the collection of health and well-being data outside of laboratory settings, in a longitudinal fashion. Wearable and mobile devices have the potential to provide low-cost, objective measures of physical activity, clinically relevant data for patient assessment, and scalable behavior monitoring in large populations. These data can be used in both interventional and observational studies to derive insights regarding the links between behavior, health. and disease, as well as to advance the personalization and effectiveness of commercial wellness applications. Today, over 400,000 participants have had their behavior tracked prospectively using accelerometers for epidemiological studies across the globe. Traditionally, epidemiologists and clinicians have relied upon self-report measures of physical activity and sleep which, while valuable in the absence of alternatives, are subject to bias and often provide partial, incomplete information Physical behavior data extracted from wearable devices are being used to derive sensor-assessed, objective measures of physical behaviors, overcoming the limitations of self-report with the aim of relating these to clinical endpoints and eventually applying the findings to preventive and predictive medicine. Moreover, the application of artificial intelligence (AI), sensor fusion, and signal processing to wearable sensor data has led to improved human activity recognition and behavioral phenotyping. Here, we review the state of the art in wearable and mobile sensing technology in epidemiology and clinical medicine and discuss how AI is changing the field

A review of automated sleep disorder detection

Automated sleep disorder detection is challenging because physiological symptoms can vary widely. These variations make it difficult to create effective sleep disorder detection models which support hu-man experts during diagnosis and treatment monitoring. From 2010 to 2021, authors of 95 scientific papers have taken up the challenge of automating sleep disorder detection. This paper provides an expert review of this work. We investigated whether digital technology and Artificial Intelligence (AI) can provide automated diagnosis support for sleep disorders. We followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines during the content discovery phase. We compared the performance of proposed sleep disorder detection methods, involving differ-ent datasets or signals. During the review, we found eight sleep disorders, of which sleep apnea and insomnia were the most studied. These disorders can be diagnosed using several kinds of biomedical signals, such as Electrocardiogram (ECG), Polysomnography (PSG), Electroencephalogram (EEG), Electromyogram (EMG), and snore sound. Subsequently, we established areas of commonality and distinctiveness. Common to all reviewed papers was that AI models were trained and tested with labelled physiological signals. Looking deeper, we discovered that 24 distinct algorithms were used for the detection task. The nature of these algorithms evolved, before 2017 only traditional Machine Learning (ML) was used. From 2018 onward, both ML and Deep Learning (DL) methods were used for sleep disorder detection. The strong emergence of DL algorithms has considerable implications for future detection systems because these algorithms demand significantly more data for training and testing when compared with ML. Based on our review results, we suggest that both type and amount of labelled data is crucial for the design of future sleep disorder detection systems because this will steer the choice of AI algorithm which establishes the desired decision support. As a guiding principle, more labelled data will help to represent the variations in symptoms. DL algorithms can extract information from these larger data quantities more effectively, therefore; we predict that the role of these algorithms will continue to expand